Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01410487 · ClinicalTrials.gov registry record

Effects of Weight Loss on Cardio-respiratory Function

A clinical trial of Obesity and Cardiovascular Abnormalities, sponsored by NYU Langone Health.

Completed
Registry status
150
Enrollment target
1
Study location

NCT01410487 is a study of Obesity and Cardiovascular Abnormalities that has completed, run by NYU Langone Health. The registered enrollment target is 150 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01410487, a study of Obesity and Cardiovascular Abnormalities, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

Obesity is a medical problem of epidemic proportions and is associated with high mortality. Obesity has significant effects on the cardiovascular system, producing structural cardiovascular changes including myocardial hypertrophy, fatty infiltration, and fibrosis; diastolic and systolic dysfunction; changes in pulmonary artery compliance; and increased aortic stiffness - all of which can lead to heart failure. Indeed, evidence suggests that obesity increases the risk for heart disease independent of other known risk factors such as coronary artery disease, hypertension, diabetes mellitus, and obstructive sleep apnea. Obesity also causes significant changes in pulmonary function, including a decrease in expiratory reserve volume and functional residual capacity and closure of peripheral airways. The exact mechanisms for the development of cardiopulmonary disease are not well understood - the pathophysiology is complex and likely multifactorial, related to altered hemodynamic load, altered metabolic activity, underlying inflammation, and increased cardiac output. Newer diagnostic modalities available at our institution such as cardiac MRI and pulmonary function tests with impulse oscillometry allow us to better evaluate cardiopulmonary dysfunction in patients with severe obesity. Cardiac MRI is especially promising as a non-invasive imaging modality in obese individuals, providing more reproducible measurements of cardiac and vascular anatomy and function relative to echocardiography. Similarly, pulmonary function testing with impulse oscillometry is more sensitive for detection of abnormalities in the distal airways especially when spirometry is normal, as frequently occurs in the severely obese symptomatic patients. The main objective of the proposed study is to evaluate the effect of obesity on quality of life and health care utilization and its relationship to cardiopulmonary disease in an ethnically diverse, underserved obese population by using state-of-the-ar

Study Locations (1)

New York

  • Bellevue Hospital Ambulatory Cinic - Suite 1D - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2011-09
Est. Completion 2013-12

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT01410487

The ClinicalTrials.gov registry entry for NCT01410487 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT01410487 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01410487 about?

NCT01410487 is a clinical study titled "Effects of Weight Loss on Cardio-respiratory Function". Obesity is a medical problem of epidemic proportions and is associated with high mortality. Obesity has significant effects on the cardiovascular system, producing structural cardiovascular changes including myocardial hypertrophy, fatty infiltration, and fibrosis; diastolic and systolic dysfunction...

What is the current status of trial NCT01410487?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2011-09. Estimated completion is 2013-12.

What conditions does trial NCT01410487 study?

This clinical trial studies the following conditions: Obesity, Cardiovascular Abnormalities.

Who is sponsoring clinical trial NCT01410487?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01410487 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.